P4: Inhaler Devices & Formulations Flashcards
what are some examples of pMDIs
standard inhalers, spacers, breath activated inhalers
what are some examples of nebulisers
pneumatic, ultrasonic
what are nebulisers
drug contained within a sterile solution of WFIs
they reproducibly and rapidly deliver correct dose to site of action with minimum waste; in reality, variations are observed
2/3 left in device, 2/3 lost during expiration, many particles too large/small
many nebulisers deliver as little as 10% of the target dose
what are pneumatic nebulisers
dominant system in market with two fluid nozzle
what are the components of a pneumatic nebuliser
unit doses, compressor, patient interface, valves/holding chamber, tubing
what are the advantages of pneumatic nebulisers
cheap, small particle sizes (1-6 microns)
what are some disadvantages of pneumatic nebulisers
variable performance, dead volume, lower output, portability
what are the components of ultrasonic nebulisers
electronic power source, synthetic piezoelectric ceramic disc, liquid reservoir, air fan, mouthpiece
what are the advantages of ultrasonic nebulisers
reproducible, small particle size (1-6microns), high output, small and quiet, low aerosol inertia
what are the disadvantages of ultrasonic nebulisers
size increase at end of life/ fill volume dependence, expensive, heats solution to 40degreesC, poor for suspensions
what are the recent advances in inhaler devices
breath assisted open vent, holding chambers, dosimetric, breath monitoring intelligent system, battery operated
enhances nebuliser output and/or shorten nebulisation time
what does SMI stand for
soft mist inhalers
what does LDI stand for
liquid dose inhalers
what are SMIs and LDIs
emerging class of inhalers
based on drug dissolved in a non-volatile liquid (usually water)
volumetric dosing like in pMDIs
aerosolised in a single breath actuation
requires tight control of droplet size via a mechanism within device
aerosol is emitted as a slow moving cloud
what is AERx LDI
hand held air-jet driven nebuliser system
utilises an electrochemical actuator to extrude drug, contained in unit dose liquid blisters, through an array of small micron sized holes
produces a uniformly fine aerosol for inhalation
uses microelectronics to guide patient into the optimum inspiratory flow rate for actuation and delivery